SL
Therapeutic Areas
Genfit Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Elafibranor (GFT505) | Primary Biliary Cholangitis (PBC) | Phase 3 |
| NIS4® Technology | NASH Diagnosis (F≥2) | Commercial |
| Drug | Indication | Phase |
|---|---|---|
| Elafibranor (GFT505) | Primary Biliary Cholangitis (PBC) | Phase 3 |
| NIS4® Technology | NASH Diagnosis (F≥2) | Commercial |